<DOC>
	<DOCNO>NCT01173575</DOCNO>
	<brief_summary>This project aim assess clinical microbiological efficacy fosfomycin ( FOM ) patient bacterial infection . Primary objective : â€¢ To assess clinical microbiological efficacy FOM patient bacterial infection . Secondary objective : - To determine rate severity unexpected adverse event . - To determine mean duration therapy FOM patient bacterial infection . Study design : Multi-center , non-interventional study</brief_summary>
	<brief_title>Assessment Efficacy FOSFOMYCIN Patients With Bacterial Infection</brief_title>
	<detailed_description>Please note InfectoPharm Arzneimittel und Consilium GmbH take sponsor responsibility German sit clinical trial Jannuary 2016 J &amp; P MEDICAL RESEARCH LTD .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>Patients bacterial infection receive FOM clinical purpose include analysis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>